AJP - Renal Physiology, Vol 271, Issue 2 304-F313, Copyright © 1996 by American Physiological Society

ARTICLES

Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors

J. J. Feng and W. J. Arendshorst
Department of Physiology, University of North Carolina at Chapel Hill 27599-7545, USA.

The development of hypertension in the spontaneously hypertensive rat (SHR) is associated with renal dysfunction; the observed renal vasoconstriction may reflect an imbalance of constrictor and dilator systems. The present studies evaluated renal vascular reactivity to arginine vasopressin (AVP) and mediation by V1 and/or V2 receptors. Renal blood flow (electromagnetic flowmetry) was measured in water-loaded, 8-wk-old SHR, Wistar-Kyoto rats (WKY), and Munich-Wistar rats. Injection of AVP (2 and 5 ng) into the renal artery caused dose-dependent renal vasoconstriction. The maximum blood flow response was approximately twofold larger in SHR than both normotensive strains. The strain difference was largely unaffected by indomethacin administration, although the reduction in blood flow produced by 5 ng AVP was 4-6% larger in both SHR and WKY during cyclooxygenase inhibition. The V1 receptor antagonist, [D-(CH2)5,Tyr(Me)2,Tyr(NH2)9]Arg8-vasopressin, blocked up to 90% of the renal vasoconstriction elicited by AVP. Intrarenal injection of the V1-receptor agonist [Phe2,Ile3,Org8]vasopressin produced renal hemodynamic effects similar to AVP; this agonist reduced renal blood flow, with twofold larger responses in SHR (-40 vs. -18% for 10 ng). In contrast, similar doses of the V2-receptor agonist 1-desamino-8-D-arginine vasopressin had no effect. These results indicate that AVP-induced vasoconstriction is mediated predominantly by the V1 receptor in the rat kidney. The enhanced vascular reactivity in 8-wk-old SHR may reflect an increased V1 receptor density and/or affinity or postreceptor signaling pathways, largely independent of buffering by the vascular V2 receptor or vasodilator prostaglandin activity. The strain difference in the vascular response to AVP may contribute to the renal vasoconstriction observed during the development of genetic hypertension.

This article has been cited by other articles:

				O. B. Vagnes, B. M. Iversen, and W. J. Arendshorst Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production Am J Physiol Renal Physiol, September 1, 2007; 293(3): F860 - F867. [Abstract] [Full Text] [PDF]

				L. T. de Richelieu, C. M. Sorensen, N.-H. Holstein-Rathlou, and M. Salomonsson NO-independent mechanism mediates tempol-induced renal vasodilation in SHR Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1227 - F1234. [Abstract] [Full Text] [PDF]

				L. M. Bivol, O. B. Vagnes, and B. M. Iversen The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension Am J Physiol Renal Physiol, August 1, 2005; 289(2): F393 - F400. [Abstract] [Full Text] [PDF]

				O. B. Vagnes, F. H. Hansen, J. J. Feng, B. M. Iversen, and W. J. Arendshorst Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1249 - F1256. [Abstract] [Full Text] [PDF]

				F. H. Hansen, O. B. Vagnes, and B. M. Iversen Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat Am J Physiol Renal Physiol, May 1, 2005; 288(5): F1023 - F1031. [Abstract] [Full Text] [PDF]

				R. W. Fallet, H. Ikenaga, J. P. Bast, and P. K. Carmines Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin Am J Physiol Renal Physiol, March 1, 2005; 288(3): F545 - F551. [Abstract] [Full Text] [PDF]

				O. B. Vagnes, F. H. Hansen, R. E. F. Christiansen, C. Gjerstad, and B. M. Iversen Age-dependent regulation of vasopressin V1a receptors in preglomerular vessels from the spontaneously hypertensive rat Am J Physiol Renal Physiol, May 1, 2004; 286(5): F997 - F1003. [Abstract] [Full Text] [PDF]

				E. K. Jackson, W. A. Herzer, C. K. Kost Jr, and S. J. Vyas Enhanced Interaction Between Renovascular {alpha}2-Adrenoceptors and Angiotensin II Receptors in Genetic Hypertension Hypertension, September 1, 2001; 38(3): 353 - 360. [Abstract] [Full Text] [PDF]

				M. Salomonsson and W. J. Arendshorst Norepinephrine-induced calcium signaling pathways in afferent arterioles of genetically hypertensive rats Am J Physiol Renal Physiol, August 1, 2001; 281(2): F264 - F272. [Abstract] [Full Text] [PDF]

				O. Vagnes, J. J. Feng, B. M. Iversen, and W. J. Arendshorst Upregulation of V1 receptors in renal resistance vessels of rats developing genetic hypertension Am J Physiol Renal Physiol, June 1, 2000; 278(6): F940 - F948. [Abstract] [Full Text] [PDF]

				K. Brannstrom and W. J. Arendshorst Resetting of exaggerated tubuloglomerular feedback activity in acutely volume-expanded young SHR Am J Physiol Renal Physiol, March 1, 1999; 276(3): F409 - F416. [Abstract] [Full Text] [PDF]

				B. M. Iversen and W. J. Arendshorst Exaggerated Ca2+ signaling in preglomerular arteriolar smooth muscle cells of genetically hypertensive rats Am J Physiol Renal Physiol, February 1, 1999; 276(2): F260 - F270. [Abstract] [Full Text] [PDF]

				B. M. Iversen and W. J. Arendshorst ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles Am J Physiol Renal Physiol, March 1, 1998; 274(3): F498 - F508. [Abstract] [Full Text] [PDF]

				J. J. Feng and W. J. Arendshorst Calcium Signaling Mechanisms in Renal Vascular Responses to Vasopressin in Genetic Hypertension Hypertension, November 1, 1997; 30(5): 1223 - 1231. [Abstract] [Full Text]